Filip Adriana Gabriela, Clichici Simona, Daicoviciu Doina, Olteanu Diana, Mureşan Adriana, Dreve Simina
Physiology Department, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Rom J Intern Med. 2008;46(4):285-93.
Photodynamic therapy (PDT) is a very promising technique used for the treatment of a variety of solid neoplasms, based on the formation of singlet oxygen induced by a photosensitizer after irradiation with visible light. The mechanism of interaction of the photosensitizers and light is discussed, along with the effects produced in the target tissue. PDT has been approved in many countries for the treatment of lung, esophageal, bladder, skin and head and neck cancers. The antitumor effects of this treatment result from the combination of direct tumor cell photodamage, destruction of tumor vasculature and activation of an immune response. The present status of clinical PDT is discussed along with the newer photosensitizers being used and their clinical roles. Despite the promising results from earlier clinical trials of PDT considerable additional work is needed to bring this new modality of treatment into modern clinical practice.
光动力疗法(PDT)是一种非常有前景的技术,用于治疗多种实体肿瘤,其基于光敏剂在可见光照射后诱导产生单线态氧。文中讨论了光敏剂与光的相互作用机制以及在靶组织中产生的效应。光动力疗法已在许多国家获批用于治疗肺癌、食管癌、膀胱癌、皮肤癌和头颈癌。这种治疗的抗肿瘤效应源于直接的肿瘤细胞光损伤、肿瘤脉管系统的破坏以及免疫反应的激活。文中讨论了临床光动力疗法的现状以及正在使用的新型光敏剂及其临床作用。尽管光动力疗法早期临床试验取得了令人鼓舞的结果,但仍需要大量额外工作才能将这种新的治疗方式引入现代临床实践。